latest news stock values companies glp-1 obesity cardiometabolic GLP-1-directed NMDA receptor antagonism for treatment BREAKING: Eli Lilly's $1 trillion

Can Peptide Therapy Provide Long-Term Relief or Just Symptom Management

* The statements made on this site have not been evaluated by the U.S

The research suggests we should view these medications not just as weight loss drugs but as weight normalizing drugs that work through complex anti-inflammatory mechanisms

Loss of muscle mass is often a concern for people taking a GLP-1, but that is overplayed, says Crotty, explaining that regardless of whether weight is lost through bariatric surgery, medication, or a calorie-restricted diet, the amount of muscle loss is similar

Phentermine and semaglutide cause completely different types of side effects because they work through completely different mechanisms